Nature Biotechnology profiled Innophore as part of its coverage on the emerging computational biology pipeline for pandemic response. The article “The pandemic pipeline” highlights how companies and research groups leveraged structural bioinformatics and AI to rapidly characterize SARS-CoV-2 proteins and identify potential drug targets, with Innophore’s Catalophore technology playing a central role in variant surveillance and binding-site analysis.